About the Choroideremia Session
Choroideremia is a rare inherited eye condition predominantly affecting males. It leads to a progressive deterioration of the choroid, retinal pigment epithelium, and retina. Symptoms typically start with night blindness during childhood, progressing to tunnel vision as peripheral vision diminishes in adolescence or early adulthood. By middle age, most individuals with choroideremia experience complete blindness.
The condition stems from mutations in the CHM gene, crucial for normal retinal and choroidal cell function. Currently, there is no cure, and management focuses on symptom alleviation and supportive care. Promising research in gene therapy aims to replace faulty genes with healthy ones, potentially slowing or halting vision loss progression in the future.
Topics Covered in Choroideremia
CHM Gene & REP1
X-Linked Inheritance
Chorioretinal Atrophy
Nyctalopia & Field Constriction
Female Carrier Phenotype
AAV Gene Therapy
Related Scientific Sessions at IOC 2027
Why Attend the Choroideremia Conference 2027
Earn CPD Credit
Sessions are CPD-accredited by The CPD Group (UK) — one CPD credit for every hour of attendance.
Present Your Research
Oral and poster slots for original Choroideremia work, reviewed by the scientific committee.
Network Globally
Meet ophthalmologists, vision scientists, and eye-care clinicians from around the world across three days.
Publish & Get Indexed
Accepted abstracts are compiled into the conference proceedings and indexed in Scopus and Web of Science.
Learn from Keynotes
Plenary lectures from leading voices shaping Choroideremia research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join IOC 2027 for the Choroideremia track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Choroideremia Conference 2027 — FAQs
What is the Choroideremia track at IOC 2027?
The Choroideremia track is a dedicated stream within IOC 2027 covering the latest research, clinical innovation, and best practice in Choroideremia. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Choroideremia sessions?
Ophthalmologists, optometrists, vision scientists, educators, doctoral students, and trainees with an interest in Choroideremia are all welcome — whether presenting or attending.
Can I present my research in the Choroideremia track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Choroideremia sessions?
Yes. IOC 2027 is a hybrid conference — attend the Choroideremia track in person in Singapore or join live online, with on-demand access afterward.
Join the IOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.